HB4CORD
Live / Registered — Registered and renewed (as of 24 Jan 2026)
What this means for you
Registered since 04 Oct 2016. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 04 Oct 2026).
Record
- Serial number
- 86708620
- Registration number
- 5052504
- Mark type
- Stylized text
- Filed
- 29 Jul 2015
- Published for opposition
- 19 Jul 2016
- Registered
- 04 Oct 2016
- Next maintenance due
- 04 Oct 2026
- Attorney of record
- Joe McKinney Muncy
Goods and services
- Class 005 — Pharmaceuticals: Stem cells for medical purposes; Medicines for human purposes, namely, medicines for the treatment of blood diseases such as leukemia, thalassemia and bone marrow failure; Medicinal agent for human use, namely, medicines for the treatment of blood diseases such as leukemia, thalassemia and bone marrow failure; Drug for medical use, namely, medicines for the treatment of blood diseases such as leukemia, thalassemia and bone marrow failure; Medicine for the treatment of blood diseases such as leukemia, thalassemia and bone marrow failure; Biological preparations for medical purposes in the nature of preparations for the treatment of blood diseases such as leukemia, thalassemia and bone marrow failure; Blood for medical purposes, namely, Haematogen, Blood plasma, Haemoglobin; Sero therapeutic medicines for the treatment of blood diseases such as leukemia, thalassemia and bone marrow failure
- Class 035 — Advertising and business services: [ Retailing and wholesaling of drugs, namely, on-line wholesale and retail store services featuring drugs ]
- Class 044 — Medical, beauty and agricultural services: [ Medical treatment services, namely, blood therapy services; Blood bank service, Blood bank services, Cord blood bank ]
Owner
- HEXUN BIOSCIENCES CO., LTD., TAOYUAN CITY, TW
- Taiwan Advance Bio-Pharmaceutical Inc., New Taipei City 221, TW
- Taiwan Advance Bio-Pharmaceutical Inc., New Taipei City 221, TW
- Taiwan Advance Bio-Pharmaceutical Inc., New Taipei City 221, TW
Prosecution history
- 24 Jan 2026 — NOTICE OF ACCEPTANCE OF PARTIAL SEC. 8 & 9 EMAILED
- 24 Jan 2026 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 24 Jan 2026 — REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8
- 24 Jan 2026 — REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED
- 24 Jan 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 21 Oct 2025 — TEAS SECTION 8 & 9 RECEIVED
- 04 Oct 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 05 Jul 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 05 Jul 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 05 Jul 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 03 Jul 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 11 Jan 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 11 Jan 2023 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 11 Jan 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 11 Jan 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED